Effects of supplementation with "Moringa oleifera Lam." in recently menopausal women

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202504475762764

Enrollment

Registered

2025-04-07

Start date

2020-01-15

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nutritional, Metabolic, Endocrine

Interventions

Supplementation

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: We will include women in our study who: - Are within the first five years of menopause - Have given their informed and voluntary consent

Exclusion criteria

Exclusion criteria: The following individuals will be excluded: - Those undergoing menopause treatment - Those receiving hypolipidemic treatment - Those who have undergone a hysterectomy - Those with chronic kidney disease (creatinine clearance < 60 ml/min) and/or confirmed liver disease - Those who wish to withdraw from the study

Design outcomes

Primary

Measure	Time frame
The variation in the severity of menopausal symptoms after 60 days of intervention	—

Secondary

Measure	Time frame
Variation in lipid parameters;Evaluation of therapeutic tolerance	—

Countries

Cameroon

Contacts

Public ContactAnne BOLI

Hopital central de Yaounde

anneboli@yahoo.fr+237675376319

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026